Solid Dosage
GEA supplies solutions for manufacturing inhalable and oral antiviral drugs ranging from blending, spray drying and particle engineering to continuous manufacturing.
Antiviral medications help the body to fight off harmful viruses such as influenza, chickenpox and the human immunodeficiency virus (HIV), to name a few. The drugs can ease symptoms and shorten the length of a viral infection. Antivirals also lower the risk of getting or spreading viruses that cause herpes and HIV. One approved antiviral treats the coronavirus that causes COVID-19.
Antiviral drugs are also preventive. They can protect you from getting viral infections or spreading a virus to others. They come in many formats, including tablets, intravenous solutions, liquids and inhaled powders.
For inhalable versions, GEA understands that homogeneity and stability are key factors. Our dry powder blending, spray drying and particle engineering capabilities ensure that the production of free-flowing, aerodynamic particles at the correct size is achievable at the scale you need.
And, with the ongoing development of oral anti-viral medications, particularly as a result of the COVID-19, pandemic, there is increased interest in the use of continuous manufacturing to accelerate process design and product optimization.
For example, the compact and fully integrated ConsiGma®4.0 platform has been designed to transfer powder into coated tablets in a shorter time frame. Plus, by combining Quality by Design (QbD) principles with Design of Experiments (DoE), it enables operators to explore the design space in a quick and easy way and expedite time-to-market.
Affichage de 4 sur 26
En tant qu’intégrateurs de systèmes, nous associons notre savoir faire en matière de technologie de process et d'engineering aux logiciels de contrôle commande et de supervision développés par des leaders du marché.
Contained Materials Handling solutions for Primary and Secondary Pharmaceuticals and Healthcare. With extensive experience within the generics sector, supply a wide range of technologies and equipment that improve and enhance the efficiency and performance of Oral Solid Dosage production.
The ConsiGma® DC for direct compression is the latest expansion of GEA's continuous portfolio for cost effective, compact, high yield manufacturing systems. It offers a robust and flexible manufacturing method for a wide range of products.
Continuous Processing is becoming more and more important in the pharmaceutical industry. GEA takes the lead in introducing this innovative technology with ConsiGma® - continuous high-shear granulation and drying lines.
La demande de café connaît une croissance rapide. Découvrez comment la technologie d'extraction continue de GEA booste le rendement, préserve les arômes et économise des ressources.
L'impact du réchauffement climatique est de plus en plus visible dans le monde entier. Les villes de toutes tailles sont confrontées au même défi : fournir à leurs communautés de la chaleur fiable et bon marché, qui soit issue de sources durables. GEA a échangé avec un spécialiste du secteur, Kenneth Hoffmann, Directeur Pompes à chaleur chez GEA Heating & Refrigeration Technologies, pour savoir comment lutter plus rapidement contre le réchauffement de notre planète.
Quelque chose a attiré l'attention de Thomas, éleveur de son état. Au lieu d'effectuer une énième démonstration produit, GEA a présenté ses dernières innovations en utilisant la réalité augmentée (RA). Cette initiative était le point de départ d'un projet de plus grande ampleur : la ferme numérique interactive de GEA.